Biogen, Inc. (BIIB)
218.61
-0.44
(-0.20%)
USD |
NASDAQ |
Sep 18, 10:30
Biogen 30-Day Average Daily Volume : 739073.4 for Sept. 17, 2026
30-Day Average Daily Volume Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| September 17, 2026 | 739073.4 |
| September 16, 2026 | 740309.2 |
| September 15, 2026 | 760282.9 |
| September 14, 2026 | 766447.8 |
| September 11, 2026 | 780858.7 |
| September 10, 2026 | 774771.4 |
| September 09, 2026 | 823555.8 |
| September 08, 2026 | 861472.8 |
| September 04, 2026 | 866297.8 |
| September 03, 2026 | 870673.3 |
| September 02, 2026 | 886717.5 |
| September 01, 2026 | 872486.4 |
| August 31, 2026 | 868064.5 |
| August 28, 2026 | 872467.3 |
| August 27, 2026 | 893594.0 |
| August 26, 2026 | 939435.8 |
| August 25, 2026 | 986769.6 |
| August 24, 2026 | 1.100M |
| August 21, 2026 | 1.154M |
| August 20, 2026 | 1.168M |
| August 19, 2026 | 1.196M |
| August 18, 2026 | 1.231M |
| August 17, 2026 | 1.247M |
| August 14, 2026 | 1.267M |
| August 13, 2026 | 1.287M |
| Date | Value |
|---|---|
| August 12, 2026 | 1.296M |
| August 11, 2026 | 1.306M |
| August 10, 2026 | 1.318M |
| August 07, 2026 | 1.373M |
| August 06, 2026 | 1.389M |
| August 05, 2026 | 1.405M |
| August 04, 2026 | 1.411M |
| August 03, 2026 | 1.426M |
| July 31, 2026 | 1.453M |
| July 30, 2026 | 1.451M |
| July 29, 2026 | 1.458M |
| July 28, 2026 | 1.408M |
| July 27, 2026 | 1.374M |
| July 24, 2026 | 1.379M |
| July 23, 2026 | 1.395M |
| July 22, 2026 | 1.392M |
| July 21, 2026 | 1.403M |
| July 20, 2026 | 1.410M |
| July 17, 2026 | 1.402M |
| July 16, 2026 | 1.394M |
| July 15, 2026 | 1.368M |
| July 14, 2026 | 1.327M |
| July 13, 2026 | 1.260M |
| July 10, 2026 | 1.204M |
| July 09, 2026 | 1.196M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Ionis Pharmaceuticals, Inc. | 3.082M |
| AbbVie, Inc. | 4.313M |
| Regeneron Pharmaceuticals, Inc. | 656937.0 |
| Gilead Sciences, Inc. | 5.607M |
| Vertex Pharmaceuticals, Inc. | 1.044M |